Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
Public ClinicalTrials.gov record NCT00157079. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety and efficacy of Immune Globulin Intravenous (Human), 10% (IGIV 10%) in subjects with primary immunodeficiency disorders.
Study identification
- NCT ID
- NCT00157079
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 24 Months and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 25, 2002 (Actual)
- Primary completion
- Dec 16, 2003 (Actual)
- Completion
- Dec 16, 2003 (Actual)
- Last update posted
- Aug 24, 2021
2002 – 2003
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children´s Hospital Los Angeles | Los Angeles | California | 90027 | — |
| Stanford University Medical Center | Stanford | California | 94304-8786 | — |
| 1st Allergy and Clinical Research Center | Englewood | Colorado | 80112 | — |
| Allergy Associates of the Palm Beaches | North Palm Beach | Florida | 33408 | — |
| University of South Florida; Asthma, Allergy & Immunology CRU | Tampa | Florida | 33613 | — |
| Rush Presbyterian - St. Lukes Medical Center | Chicago | Illinois | 60612 | — |
| Children´s Hospital Boston | Boston | Massachusetts | 02115 | — |
| Allergy, Asthma & Immunology Assoc. | Omaha | Nebraska | 68124 | — |
| Asthma and Allergy Center | Papillion | Nebraska | 68046 | — |
| Montefiore Medical Center, Albert Einstein College of Medicine | The Bronx | New York | 10461 | — |
| Pediatric Allergy/Immunology Associates | Dallas | Texas | 75230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00157079, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00157079 live on ClinicalTrials.gov.